Non-canonical Caspase-8 Activation on Autophagosomal Membranes
Non-canonical Caspase-8 Activation on Autophagosomal Membranes
批准号:
10448458
负责人:
HONG-GANG WANG
金额:
$34.14万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2023-07-31
关键词:
Acute Myelocytic LeukemiaAdaptor Signaling ProteinApoptosisApoptoticAutophagocytosisAutophagosomeBinding ProteinsBiogenesisCASP8 and FADD-like apoptosis regulating proteinCASP8 geneCaspaseCell DeathCell SurvivalCellsCessation of lifeChildhood Acute Myeloid LeukemiaComplexDataDeath DomainDegradation PathwayEatingGene RearrangementGoalsHypoxiaImpairmentLysosomesMLL geneMalignant NeoplasmsMammalian CellMediatingMembraneMembrane ProteinsMixed-Lineage LeukemiaModelingMolecularNeoplasm MetastasisNutrientProcessProteinsReceptor SignalingRecyclingRegulationResearchSignal TransductionStarvationSystemTestingTherapeuticVacuoleVesicleYeastsanti-canceraposomearmcancer cellcancer therapyclinically relevantenvironmental stressorimprovedin vivoin vivo Modelinhibition of autophagyinhibitornovelnovel strategiesrecruitsealtargeted cancer therapytraffickingtumor initiationtumorigenesistumorigenic
中文摘要
项目摘要/摘要
这个项目的目标是检验一种假设,即未成熟的自噬小体的积累
膜诱导caspase-8的非规范激活,将细胞保护性自噬转换为细胞凋亡
寻找一种新的抗癌策略。自噬在癌症中是一把双刃剑,因为它可以抑制
致癌或促进癌细胞存活。由于缺乏选择性的自噬通量抑制剂,
很难确定抑制自噬是否是有效的癌症策略。我们和其他人已经证明了这一点
自噬体膜可以作为细胞内死亡诱导信号复合体的平台
(IDISC)激活不依赖于死亡受体信号的caspase-8。从机制上讲,iDISC招募
前caspase-8通过两个臂:1)ATG12-ATG5:FADD:caspase-8;和2)LC3-II:
P62:caspase-8。由于ATG12-ATG5在膜关闭和密封时从噬菌体解离
自噬小体运输到溶酶体进行降解,我们假设抑制噬菌体关闭将
稳定iDISC组件以激活caspase-8。事实上,我们的初步数据显示,细胞缺乏
ATG2A/B或VMP1,两个吞噬细胞关闭的调节者,积累未成熟的吞噬细胞,促进
IDISC介导的caspase-8激活。我们认为,阐明噬菌体的分子机制
封闭将导致更多有选择性的自噬抑制靶点,并为癌症提供新的机会
心理治疗。我们将从以下几个具体目标来考察我们的假说:1)为了证明
未成熟噬菌体启动iDISC介导的caspase-8激活及其分子调控特性
2)验证ATG2A/B和VMP1调控噬菌体的假说
通过输送含有ATG9的膜关闭;3)证明受损的吞噬细胞
CLOSE可在体内将自噬转换为IDISC介导的凋亡,以抑制儿童急性髓系白血病
伴有MLL基因重排的白血病(AML)。
英文摘要
Project Summary/Abstract
The goal of this project is to test the hypothesis that an accumulation of immature autophagosomal
membranes induces the non-canonical activation of caspase-8 to switch cytoprotective autophagy to apoptosis
for a novel anti-cancer strategy. Autophagy is a double-edged sword in cancer as it can either suppress
oncogenesis or promote cancer cell survival. The lack of selective inhibitors of autophagic flux has made it
difficult to determine if inhibition of autophagy is a valid cancer strategy. We, and others, have demonstrated that
autophagosomal membranes can serve as platforms for an intracellular death-inducing signaling complex
(iDISC) that activates caspase-8 independent of death receptor signaling. Mechanistically, the iDISC recruits
pro-caspase-8 to autophagosomal membranes by two arms: 1) ATG12-ATG5: FADD: caspase-8; and 2) LC3-II:
p62: caspase-8. As ATG12-ATG5 dissociates from the phagophore upon membrane closure and sealed
autophagosomes traffic to lysosomes for degradation, we hypothesize that inhibition of phagophore closure will
stabilize iDISC assembly for caspase-8 activation. Indeed, our preliminary data reveal that cells deficient in
ATG2A/B or VMP1, two regulators of phagophore closure, accumulate immature phagophores that promote
iDISC-mediated caspase-8 activation. We propose that elucidation of the molecular mechanisms of phagophore
closure will lead to more selective targets for autophagy inhibition and present novel opportunities for cancer
therapy. We will investigate our hypothesis in the following specific aims: 1) to demonstrate that the accumulation
of immature phagophores initiates iDISC-mediated caspase-8 activation and characterize molecular regulators
of non-canonical caspase-8 activation; 2) to test the hypothesis that ATG2A/B and VMP1 regulate phagophore
closure through the delivery of ATG9-containing membranes; 3) to demonstrate that impaired phagophore
closure can switch autophagy to iDISC-mediated apoptosis in vivo for the suppression of pediatric acute myeloid
leukemia (AML) with MLL (mixed lineage leukemia) gene rearrangements.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autophagy Heterogeneity and Tumor Metastasis
-
批准号:10212775
-
项目类别:
-
资助金额:$41.7万
-
财政年份:2021
-
负责人:HONG-GANG WANG
-
依托单位:
Autophagosome closure by the ESCRT machinery
-
批准号:10383918
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:HONG-GANG WANG
-
依托单位:
Autophagosome closure by the ESCRT machinery
-
批准号:10132346
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2018
-
负责人:HONG-GANG WANG
-
依托单位:
Non-canonical Caspase-8 Activation on Autophagosomal Membranes
-
批准号:10214562
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2018
-
负责人:HONG-GANG WANG
-
依托单位:
Non-canonical Caspase-8 Activation on Autophagosomal Membranes
-
批准号:9983008
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2018
-
负责人:HONG-GANG WANG
-
依托单位:
Autophagosome closure by the ESCRT machinery
-
批准号:9884792
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2018
-
负责人:HONG-GANG WANG
-
依托单位:
Autophagosome closure by the ESCRT machinery
-
批准号:10703381
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2018
-
负责人:HONG-GANG WANG
-
依托单位:
Autophagosome closure by the ESCRT machinery
-
批准号:10453304
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2018
-
负责人:HONG-GANG WANG
-
依托单位:
Targeting autophagy in the TME
-
批准号:8395589
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2012
-
负责人:HONG-GANG WANG
-
依托单位:
Targeting autophagy in the TME
-
批准号:8495299
-
项目类别:
-
资助金额:$18.77万
-
财政年份:2012
-
负责人:HONG-GANG WANG
-
依托单位:
Regulation of Autophagy and Tumorigenesis by Bif-1
-
批准号:8016110
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2009
-
负责人:HONG-GANG WANG
-
依托单位:
Regulation of Autophagy and Tumorigenesis by Bif-1
-
批准号:8215872
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2009
-
负责人:HONG-GANG WANG
-
依托单位:
Regulation of Autophagy and Tumorigenesis by Bif-1
-
批准号:8447365
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2009
-
负责人:HONG-GANG WANG
-
依托单位:
Regulation of Autophagy and Tumorigenesis by Bif-1
-
批准号:7653080
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2009
-
负责人:HONG-GANG WANG
-
依托单位:
Regulation of Autophagy and Tumorigenesis by Bif-1
-
批准号:7798244
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2009
-
负责人:HONG-GANG WANG
-
依托单位:
Development of Small Molecule Antagonists of Bcl2/BclXL
-
批准号:7214568
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2006
-
负责人:HONG-GANG WANG
-
依托单位:
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis
-
批准号:6721374
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2002
-
负责人:HONG-GANG WANG
-
依托单位:
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis
-
批准号:6471623
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2002
-
负责人:HONG-GANG WANG
-
依托单位:
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis
-
批准号:7036487
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2002
-
负责人:HONG-GANG WANG
-
依托单位:
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis
-
批准号:6871234
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2002
-
负责人:HONG-GANG WANG
-
依托单位: